Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker.

Archive ouverte

Ando, Kunie | Dourlen, Pierre | Sambo, Anne-Véronique | Bretteville, Alexis | Bélarbi, Karim | Vingtdeux, Valérie | Eddarkaoui, Sabiha | Drobecq, Hervé | Ghestem, Antoine | Bégard, Séverine | Demey-Thomas, Emmanuelle | Melnyk, Patricia | Smet, Caroline | Lippens, Guy | Maurage, Claude-Alain | Caillet-Boudin, Marie-Laure | Verdier, Yann | Vinh, Joelle | Landrieu, Isabelle | Galas, Marie-Christine | Blum, David | Hamdane, Malika | Sergeant, Nicolas | Buée, Luc

Edité par CCSD -

International audience. A prerequisite to dephosphorylation at Ser-Pro or Thr-Pro motifs is the isomerization of the imidic peptide bond preceding the proline. The peptidyl-prolyl cis/trans isomerase named Pin1 catalyzes this mechanism. Through isomerization, Pin1 regulates the function of a growing number of targets including the microtubule-associated tau protein and is supposed to be deregulated Alzheimer's disease (AD). Using proteomics, we showed that Pin1 is posttranslationally modified on more than 5 residues, comprising phosphorylation, N-acetylation, and oxidation. Although Pin1 expression remained constant, Pin1 posttranslational two-dimensional pattern was modified by tau overexpression in a tau-inducible neuroblastoma cell line, in our THY-Tau22 mouse model of tauopathy as well as in AD. Interestingly, in all of these systems, Pin1 modifications were very similar. In AD brain tissue when compared with control, Pin1 is hyperphosphorylated at serine 16 and found in the most insoluble hyperphosphorylated tau fraction of AD brain tissue. Furthermore, in all tau pathology conditions, acetylation of Pin1 may also contribute to the differences observed. In conclusion, Pin1 displays several posttranslational modifications, which are specific in tauopathies and may be useful as biomarker.

Consulter en ligne

Suggestions

Du même auteur

Pin1 allows for differential Tau dephosphorylation in neuronal cells.

Archive ouverte | Hamdane, Malika | CCSD

Neurofibrillary degeneration is likely to be related to abnormal Tau phosphorylation and aggregation. Among abnormal Tau phosphorylation sites, pThr231 is of particular interest since it is associated with early stages of Alzheime...

Comment les acteurs moléculaires de la pathologie Alzheimer permettent de comprendre la démence ? Quelles conséquences diagnostiques et thérapeutiques ?

Archive ouverte | Buée, Luc | CCSD

International audience

New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease

Archive ouverte | Sergeant, Nicolas | CCSD

International audience. Alzheimer's Disease is a devastating dementing disease involving amyloid deposits, neurofibrillary tangles, progressive and irreversible cognitive impairment. Today, only symptomatic drugs ar...

Chargement des enrichissements...